ME/CFS clinicians unanimously agreed antivirals and immune modulating agents were the top two drugs they's like to explore during the FDA's Workshop April 26, 2013. FDA posed the question: "If you had a drug or intervention you'd like to explore, what would be your top one or two or three choice?" Drs. Bateman, Klimas, Corbin, Chu, & Montoya were on the panel. Dr. Bateman answered with her priority list (below) & other panel members concurred: 1. Antivirals 2. Immune modulating agents For symptom relief: 3. Pain medications 4. Stimulants for cognition 5. Sleep medications 6. Orthostatic intolerance medications Audience members added: 7. Large-scale Rituxan clinical trial 8. VO2 max agents This part of the meeting is on page 66 the MS Word transcription, post #125 on the FDA Workshop thread. Hope future FDA meetings will address the ME/CFS priority list since discussion was limited this time, "just say them, not discuss them" was asked of the panel.